Early this year, we moved into our new forward-looking premises with state-of-the-art production and lab facilities. In our new home, we can continue to expand in our research, operational and commercial activities. This growth and the associated, investments require specific reinforcement and expanded of our management team. We are pleased to announce that Sander Heijmans has joined the Winclove board.
Chief Future/Financial Officer (CFO)
Sanders’ new position as CFO is twofold. On the one hand, the F stands for Future, where he will help Winclove grow and flesh out our vision, mission and strategy. And on the other hand, the F stands for Financial, where the focus is on investing and growing in the broadest sense of the word. With Sander’s arrival, we welcome a highly experienced CFO to our Winclove family, who fully embraces our ambition to become the best company for the world.
Contributing to further growth
Sander has a background as a chartered accountant and has extensive experience in financial (executive) positions at renowned companies. Sander: “I look forward to using my strategic and financial expertise to further develop this fine company. With a strong focus on growth and strategic planning, I want to play a key role in stimulating and future-proofing the expansion of Winclove Probiotics. In addition, I want to do my bit for Winclove’s mission to make a positive impact on people’s health worldwide.”
